Scholars Central

Review articlePublished 2014

Bringing p53 into the Clinic

Authors: Ern Yu Tan, Chit Fang Cheok

Cancer Science & Therapy

Volume 6 · Issue 9

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The use of p53 as a biological marker to predict chemotherapeutic outcome has been challenging, with clinical research showing positive as well as negative correlations with p53 mutations. Recent research reveals the complexity that underlies the use of p53 as a single predictive marker as well as the challenges associated with classifying p53 mutations. It is becoming clear that various p53 mutations are associated with differential treatment response and outcomes. In addition, different drug regimens could also play a role in modifying the effects of p53 mutations on therapeutic outcome. Finally, we discuss improvements in the diagnostic detection of p53 mutations and gene signatures that may better reflect p53 functionality in tumors, which may serve as a more reliable tool in correlating p53 mutations to clinical response.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Ern Yu Tan”
  • BylineArticles whose byline prints “Chit Fang Cheok”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels